Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
11901
CALL
DELISTED
Regulus Therapeutics
RGLS
| $21.6K | ﹤0.01% |
13,700
-22,700
| -62% | -$34.9K |
|
|
LYRA
11902
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $21.3K | ﹤0.01% |
2,069
+1,811
| +702% | +$19.9K |
|
|
ELEV
11903
DELISTED
Elevation Oncology
ELEV
| $21.3K | ﹤0.01% |
+37,925
| New | +$22.4K |
|
|
GRRRW
11904
Gorilla Technology Group Warrant
GRRRW
$2.48M
| $21K | ﹤0.01% |
+20,956
| New | +$3.28K |
|
11905
AquaBounty Technologies
AQB
$6.95M
| $20.9K | ﹤0.01% |
33,376
+6,138
| +23% | +$6.03K |
|
11906
CALL
Ocugen
OCGN
$471M
| $20.7K | ﹤0.01% |
25,600
+7,800
| +44% | +$7.14K |
|
|
ALLK
11907
CALL
DELISTED
Allakos
ALLK
| $20.6K | ﹤0.01% |
17,000
+200
| +1% | +$210 |
|
11908
Solarmax Technology
SMXT
$14.4M
| $20.5K | ﹤0.01% |
1,054
-820
| -44% | -$11.7K |
|
11909
ZW Data Action Technologies
CNET
$5.28M
| $20.5K | ﹤0.01% |
+11,362
| New | +$21.6K |
|
11910
Vivani Medical
VANI
$126M
| $20.1K | ﹤0.01% |
17,333
+7,311
| +73% | +$9.25K |
|
11911
CALL
BeyondSpring
BYSI
$25.6M
| $19.7K | ﹤0.01% |
12,100
-8,600
| -42% | -$16.9K |
|
11912
Invivyd
IVVD
$265M
| $19.7K | ﹤0.01% |
44,471
+21,917
| +97% | +$17.1K |
|
11913
PUT
Armata Pharmaceuticals
ARMP
$190M
| $19.1K | ﹤0.01% |
10,300
| – | – |
|
11914
374Water
SCWO
$46.6M
| $19K | ﹤0.01% |
2,788
+1,445
| +108% | +$17.8K |
|
11915
PUT
ReWalk Robotics
LFWD
$21.5M
| $19K | ﹤0.01% |
+917
| New | +$24.2K |
|
11916
Dolphin Entertainment
DLPN
$14.8M
| $19K | ﹤0.01% |
+17,774
| New | +$21.4K |
|
11917
Sentage Holdings
SNTG
$4.91M
| $19K | ﹤0.01% |
+10,471
| New | +$21.7K |
|
|
USAS
11918
Americas Gold and Silver
USAS
$1.94B
| $18.9K | ﹤0.01% |
20,096
-1,204
| -6% | -$1.22K |
|
11919
Inuvo
INUV
$12M
| $18.9K | ﹤0.01% |
+2,921
| New | +$8.48K |
|
|
ASRT
11920
PUT
DELISTED
Assertio
ASRT
| $18.9K | ﹤0.01% |
1,447
+307
| +27% | +$4.58K |
|
|
SVRN
11921
OceanPal Inc
SVRN
$16.5M
| $18.8K | ﹤0.01% |
+32
| New | +$23.8K |
|
11922
CALL
PLAYSTUDIOS Inc
MYPS
$60.5M
| $18.8K | ﹤0.01% |
+10,100
| New | +$17.3K |
|
11923
PSQ Holdings Warrants
PSQH.WS
$1.04M
| $18.8K | ﹤0.01% |
+23,483
| New | +$9.05K |
|
|
FTH
11924
Faeth Therapeutics
FTH
$858M
| $18.6K | ﹤0.01% |
1,903
-2,618
| -58% | -$26.3K |
|
11925
CEMIG Preferred Shares
CIG
$5.66B
| $18.6K | ﹤0.01% |
+10,523
| New | +$20.4K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.